-
Advertisement
OpinionLetters

Letters to the Editor, May 13, 2017

Reading Time:4 minutes
Why you can trust SCMP
Patients wait to be attended to in the emergency department at Queen Elizabeth Hospital in Jordan. Public hospitals and government subsidies are the only hope for decent medical treatment for many patients in Hong Kong. Photo: Sam Tsang
Letters

Drug subsidy is a question of humanity

I wish to express my opinion on whether the Hospital Authority and government should subsidise costly drugs (“Subsidising new tumour-fighting drug ­depends on effectiveness not cost”, May 3). I was stunned to learn that a 36-year-old died after failing to get a new drug for her rare genetic disease subsidised. It is time for greater awareness of patients’ rights.

The medicine this patient needed cost around HK$20,000 a month and was not listed under the Drug Formulary for public hospitals, that is, it was not a standard drug subsidised by the government.

Advertisement

The government wants to be certain of the effectiveness of costly drugs ­before subsidising them. ­However, I think it should be more ­humanitarian in its ­approach, especially as the Alliance for Rare Diseases estimates that about 7,500 patients in the city have rare diseases.

The Hong Kong government has huge cash reserves, it can easily help the needy get better medical treatment. The Drug Formulary should be revised for maximum mitigation of the financial ­burden of patients.

Advertisement

The government could also cooperate with pharmaceutical firms to develop drugs at a lower cost, and put more resources into research for new and ­improved drugs.

Heidi Keung, Kowloon Tong

Advertisement
Select Voice
Select Speed
1.00x